Metastatic vipoma arising from colonic primary tumour

Eur J Surg Oncol. 1989 Aug;15(4):386-9.

Abstract

We describe a case of a tumour of the sigmoid colon with hepatic metastases in a patient with previously documented ulcerative colitis. A diagnosis of metastatic vipoma was made on the basis of high plasma levels of vasoactive intestinal polypeptide (VIP). Profuse diarrhoea and profound metabolic upset were corrected by the use of a somatostatin analogue SMS 201-995, whilst conventional cytotoxic therapy produced a significant tumour response with return of the plasma VIP level to normal.

Publication types

  • Case Reports

MeSH terms

  • Adenoma, Islet Cell / secondary*
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Colitis, Ulcerative / blood
  • Colitis, Ulcerative / pathology
  • Colostomy
  • Combined Modality Therapy
  • Female
  • Humans
  • Liver Neoplasms / blood
  • Liver Neoplasms / pathology
  • Liver Neoplasms / secondary
  • Liver Neoplasms / therapy
  • Octreotide / administration & dosage
  • Pancreatic Neoplasms / blood
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / secondary*
  • Pancreatic Neoplasms / therapy
  • Sigmoid Neoplasms / blood
  • Sigmoid Neoplasms / pathology*
  • Sigmoid Neoplasms / therapy
  • Streptozocin / administration & dosage
  • Vasoactive Intestinal Peptide / blood
  • Vipoma / blood
  • Vipoma / pathology
  • Vipoma / secondary*
  • Vipoma / therapy

Substances

  • Vasoactive Intestinal Peptide
  • Streptozocin
  • Octreotide